We are live on ! Find out more
BM

Brandywine Managers Portfolio holdings

AUM $170M
1-Year Est. Return 10.01%
This Fund
S&P 500
This Quarter Est. Return
+1.32%
1 Year Est. Return
+10.01%
3 Year Est. Return
+53.1%
5 Year Est. Return
+7.42%
10 Year Est. Return
+248.69%
AUM
$93M
AUM Growth
-$1.52M
Cap. Flow
-$809K
Cap. Flow %
-0.87%
Top 10 Hldgs %
83.21%
Holding
38
New
2
Increased
11
Reduced
1
Closed
3

Top Buys

Rank Stock Value
1
VKTX icon
Viking Therapeutics
VKTX
+$474K
2
CRWD icon
CrowdStrike
CRWD
+$350K
3
SNOW icon
Snowflake
SNOW
+$300K
4
IOT icon
Samsara
IOT
+$300K
5
BEAM icon
Beam Therapeutics
BEAM
+$292K

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.68M
2
CPB icon
Campbell Soup
CPB
+$1.09M
3
MORF
Morphic Holding, Inc. Common Stock
MORF
+$487K
4
FULC icon
Fulcrum Therapeutics
FULC
+$162K

Sector Composition

Rank Sector Weight
1 Technology 41.91%
2 Healthcare 11.99%
3 Financials 0.95%
4 Consumer Discretionary 0.19%
5 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVO
26
Novo Nordisk
NVO
$208B
$503K 0.54%
4,222
+740
+21% +$98.7K
GPCR icon
27
Structure Therapeutics
GPCR
$3.44B
$485K 0.52%
11,057
– –
S icon
28
SentinelOne
S
$6.87B
$455K 0.49%
19,001
– –
SDGR icon
29
Schrodinger
SDGR
$1.14B
$387K 0.42%
20,886
– –
BEAM icon
30
Beam Therapeutics
BEAM
$2.67B
$277K 0.3%
+11,306
New +$292K
RLAY icon
31
Relay Therapeutics
RLAY
$4.09B
$272K 0.29%
38,429
+6,622
+21% +$49.5K
GH icon
32
Guardant Health
GH
$21.3B
$235K 0.25%
10,233
+3,081
+43% +$87.2K
TXG icon
33
10x Genomics
TXG
$5.97B
$227K 0.24%
10,073
– –
MBLY icon
34
Mobileye
MBLY
$2.04B
$179K 0.19%
13,067
– –
ABCL icon
35
AbCellera Biologics
ABCL
$1.78B
$74.1K 0.08%
28,488
– –
CPB icon
36
Campbell Soup
CPB
$6.67B
– –
-24,014
Closed -$1.09M
FULC icon
37
Fulcrum Therapeutics
FULC
$283M
– –
-26,127
Closed -$162K
MORF
38
DELISTED
Morphic Holding, Inc. Common Stock
MORF
– –
-14,286
Closed -$487K
1
2

Similar funds

CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
FH
Financial Harvest Winter Park, Florida $170M AUM 20.71% 1-Year Est. Return
RWFS
Rayburn West Financial Services Nashville, Tennessee $170M AUM
RFO
RiverGlades Family Offices Naples, Florida $170M AUM
DWM
Daner Wealth Management Alpharetta, Georgia $170M AUM 15.3% 1-Year Est. Return
AGC
ARP Global Capital Dubai $170M AUM
AWA
Argo Wealth Advisory Mclean, Virginia $170M AUM
LOIP
Live Oak Investment Partners Austin, Texas $169M AUM 17.72% 1-Year Est. Return

Brandywine Managers's Q3 2024 Portfolio in Review

As of Q3 2024, Brandywine Managers held 38 positions worth $93M, down 1.6% from $94.5M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Brandywine Managers's Q3 2024 filing shows 2 new, 11 increased, 1 reduced and 3 closed positions. Its largest new stake was Viking Therapeutics: 8,082 shares worth $512K. The largest sale was NVIDIA, an estimated $1.68M.

By sector, the portfolio is most concentrated in Technology at 42% of assets, down from 45% a quarter earlier, followed by Healthcare and Financials.

  • Brandywine Managers's largest Q3 2024 buy was Viking Therapeutics: 8,082 shares worth $512K.
  • Brandywine Managers added most to CrowdStrike in Q3 2024, an estimated $350K increase.
  • Brandywine Managers's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $1.68M.
  • Brandywine Managers fully exited Campbell Soup in Q3 2024, selling an estimated $1.09M.
  • Brandywine Managers's ten largest holdings make up 83% of its $93M portfolio in Q3 2024.
  • Brandywine Managers opened 2 new positions and closed 3 in Q3 2024.
  • Brandywine Managers's portfolio value fell 1.6% quarter-over-quarter to $93M.

Based on Brandywine Managers's 13F filing for Q3 2024, filed 14 Nov 2024.